PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma

Novartis Investigative Site, Camperdown

Novartis Investigative Site, Melbourne

Novartis Investigative Site, Riyadh

Thomas Jefferson University, Philadelphia

Novartis Investigative Site, Milan

Novartis Investigative Site, Hamburg

Emory University School of Medicine-Winship Cancer Institute, Atlanta

Novartis Investigative Site, Pamplona

Novartis Investigative Site, Salamanca

Novartis Investigative Site, Bologna

Novartis Investigative Site, Nantes

Novartis Investigative Site, Cologne

Novartis Investigative Site, Lille

Novartis Investigative Site, Heidelberg

Novartis Investigative Site, Paris

Novartis Investigative Site, Poitiers

Stanford University, Palo Alto

Novartis Investigative Site, Würzburg

Oregon Health Sciences University, Portland

Fred Hutch Cancer Research, Seattle

Novartis Investigative Site, Singapore

Novartis Investigative Site, Singapore

Novartis Investigative Site, Ramat Gan

Novartis Investigative Site, Tel Aviv

Dana Farber Cancer Institute, Boston

Novartis Investigative Site, Salvador

Novartis Investigative Site, São Paulo

Novartis Investigative Site, Calgary

Novartis Investigative Site, Athens

Novartis Investigative Site, Thessaloniki

Novartis Investigative Site, Nagoya

Novartis Investigative Site, Sapporo

Novartis Investigative Site, Kyoto

Novartis Investigative Site, Sendai

Novartis Investigative Site, Birmingham

Novartis Investigative Site, Glasgow